AU2427300A - Use of extracts from ginkgo biloba leaves for treating sleep disorders - Google Patents
Use of extracts from ginkgo biloba leaves for treating sleep disordersInfo
- Publication number
- AU2427300A AU2427300A AU24273/00A AU2427300A AU2427300A AU 2427300 A AU2427300 A AU 2427300A AU 24273/00 A AU24273/00 A AU 24273/00A AU 2427300 A AU2427300 A AU 2427300A AU 2427300 A AU2427300 A AU 2427300A
- Authority
- AU
- Australia
- Prior art keywords
- extracts
- sleep disorders
- ginkgo biloba
- biloba leaves
- treating sleep
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Botany (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to the use of extracts from Ginkgo biloba leaves in order to produce a medicament used for treating sleep disorders. It has been shown that the use of Ginkgo biloba extracts, in particular, for treating certain sleep disorders, for example, sleep disorders experienced by depressive patients or by older people, can normalize the sleep architecture and thus increase the quality of sleep.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH00479/99A CH693498A5 (en) | 1999-03-16 | 1999-03-16 | Use of extracts of Ginkgo biloba leaves to treat sleep disorders. |
CH479/99 | 1999-03-16 | ||
PCT/CH2000/000087 WO2000054791A1 (en) | 1999-03-16 | 2000-02-17 | Use of extracts from ginkgo biloba leaves for treating sleep disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2427300A true AU2427300A (en) | 2000-10-04 |
Family
ID=4187952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU24273/00A Abandoned AU2427300A (en) | 1999-03-16 | 2000-02-17 | Use of extracts from ginkgo biloba leaves for treating sleep disorders |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1161252B1 (en) |
AT (1) | ATE245432T1 (en) |
AU (1) | AU2427300A (en) |
CH (1) | CH693498A5 (en) |
DE (1) | DE50002999D1 (en) |
ES (1) | ES2203418T3 (en) |
WO (1) | WO2000054791A1 (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4110620A1 (en) * | 1991-04-02 | 1992-10-08 | Deinlein Kalb Hans | Use of extract from Gingko biloba leaves - for treating sleep apnea, opt. co-administered with theophylline |
JP3343708B2 (en) * | 1995-07-14 | 2002-11-11 | 森谷健康食品株式会社 | Healthy food for sleep |
JPH0923851A (en) * | 1995-07-14 | 1997-01-28 | Moritani Kenko Shokuhin Kk | Health food for quiet sleep |
JPH0923849A (en) * | 1995-07-14 | 1997-01-28 | Moritani Kenko Shokuhin Kk | Health food for quiet sleep |
-
1999
- 1999-03-16 CH CH00479/99A patent/CH693498A5/en not_active IP Right Cessation
-
2000
- 2000-02-17 WO PCT/CH2000/000087 patent/WO2000054791A1/en active IP Right Grant
- 2000-02-17 AU AU24273/00A patent/AU2427300A/en not_active Abandoned
- 2000-02-17 DE DE50002999T patent/DE50002999D1/en not_active Expired - Lifetime
- 2000-02-17 AT AT00902530T patent/ATE245432T1/en not_active IP Right Cessation
- 2000-02-17 EP EP00902530A patent/EP1161252B1/en not_active Expired - Lifetime
- 2000-02-17 ES ES00902530T patent/ES2203418T3/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE245432T1 (en) | 2003-08-15 |
ES2203418T3 (en) | 2004-04-16 |
EP1161252B1 (en) | 2003-07-23 |
DE50002999D1 (en) | 2003-08-28 |
EP1161252A1 (en) | 2001-12-12 |
CH693498A5 (en) | 2003-09-15 |
WO2000054791A1 (en) | 2000-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY127980A (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
IL144643A0 (en) | Jak-3 inhibitors for treating allergic disorders | |
PL362690A1 (en) | Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders | |
HRP20020593B1 (en) | Brain, spinal and nerve injury treatment | |
IL127943A (en) | Pharmaceutical and cosmetic compositions for the treatment of skin disorders | |
IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
MY137435A (en) | Retinoid compounds (i) | |
IL160232A0 (en) | Oral compositions for the treatment of scalp disorders | |
AU5170499A (en) | Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis | |
IL148963A0 (en) | Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba | |
IL115589A0 (en) | Use of cck-b antagonists in pharmaceutical compositions | |
BG105962A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
BG103687A (en) | Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system | |
EP1262197A3 (en) | Combination treatment for sleep disorders including sleep apnea | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
BG108452A (en) | Tablet comprising cetirizine and pseudoephedrine | |
GB0020504D0 (en) | Therapeutic method | |
HK1060558A1 (en) | 2H-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof. | |
WO2002005801A3 (en) | Compositions containing diacyltartaric salts of (e)-metanicotine | |
EE200100689A (en) | Use of IL6RIL6 Chimera for the preparation of a medicament for the treatment of neurological diseases, and pharmaceutical composition | |
IL143382A0 (en) | Human adult astrocytes, their preparation and uses thereof | |
WO1999020291A3 (en) | Pharmaceutical grade ginkgo biloba | |
WO2000061125A3 (en) | Osanetant in the treatment of mood disorders | |
AU2427300A (en) | Use of extracts from ginkgo biloba leaves for treating sleep disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |